CVE-2014-1403

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in name.html in easyXDM before 2.4.19 allows remote attackers to inject arbitrary web script or HTML via the location.hash value.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.43%
Vendor Advisory secunia.com Vendor Advisory github.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://seclists.org/fulldisclosure/2014/Feb/5 mailing list exploit
https://exchange.xforce.ibmcloud.com/vulnerabilities/90876 vdb entry
https://github.com/oyvindkinsey/easyXDM/commit/a3194d32c25a0d27a10a47304eb9c9be93ffbf13#diff-6489956f1e1f52236929b4d33cbeb2db patch exploit
http://secunia.com/advisories/56634 third party advisory vendor advisory
https://github.com/oyvindkinsey/easyXDM/releases/tag/2.4.19 patch vendor advisory
http://blog.kotowicz.net/2014/01/xssing-with-shakespeare-name-calling.html exploit
http://osvdb.org/102803 vdb entry
http://www.securityfocus.com/bid/65291 vdb entry

Frequently Asked Questions

What is the severity of CVE-2014-1403?
CVE-2014-1403 has been scored as a medium severity vulnerability.
How to fix CVE-2014-1403?
To fix CVE-2014-1403, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-1403 being actively exploited in the wild?
It is possible that CVE-2014-1403 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.